Search Results

Ireland is entering a 1.5 to 2 billion euro National Electronic Health Record programme with a poor record on large health IT projects. PPARS and the 2021 cyberattack were governance failures, not technology failures, and AI project tools inherit the optimism they are fed. This analysis argues that the discipline the HSE needs already exists in Irish pharma and MedTech under GAMP 5 and the FDA's Computer Software Assurance guidance.

Ireland built a life-science powerhouse by being the easiest place in Europe for global talent to land and stay. The proposed move from five to eight years for citizenship changes the terms on which the sector's skilled workforce agreed to come here. This analysis looks at what it means for engineers and scientists on Critical Skills permits, for the companies that depend on them, and what a fairer Bill would look like.

The Government wants to raise the residency requirement for Irish citizenship from five years to eight, with language and civics tests on top. This analysis looks at who actually carries the weight of that change: the internationally trained nurses, care assistants and pharmaceutical professionals who keep Irish hospitals, nursing homes and manufacturing plants running, and how Ireland would compare with Canada, Australia and the rest of Europe.

Building on Sreedevi Vijayakumari's analysis of Ireland's infrastructure overruns, this article examines how digital project management practices close the operational delivery gaps behind scope creep, slipped milestones, and portfolio blind spots across public works and life sciences.

MIT research found that 95% of enterprise generative AI pilots show no measurable P&L impact, despite up to €36.8bn of global investment. The failure is not the technology, it is governance: cost is billed and legible, return is diffuse and uninstrumented. A seven-band cost taxonomy, eight load-bearing equations and the make-versus-rent crossover that Irish life sciences boards need to close the gap.

A Priya Life Science White Paper analyzing the pivotal policy dossiers of the 2026 Irish Presidency, the economic stakes for biopharma manufacturing, and key strategic recommendations.

Our founder, Sreepriya Prasannan, shares her experience from the invitation-only Fierce Summit 2026 at Dogpatch Labs, Dublin-from high-impact VC mentoring sessions to the power of hallway conversations with fellow women tech founders.